SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-Q’ for 9/30/13 – ‘R41’

On:  Tuesday, 11/12/13, at 8:52am ET   ·   For:  9/30/13   ·   Accession #:  1564590-13-1200   ·   File #:  0-19627

Previous ‘10-Q’:  ‘10-Q’ on 8/9/13 for 6/30/13   ·   Next:  ‘10-Q’ on 5/12/14 for 3/31/14   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/12/13  Biolase, Inc                      10-Q        9/30/13   65:8.2M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    543K 
 2: EX-4        Ex-4.2                                              HTML     65K 
 3: EX-4        Ex-4.3                                              HTML     63K 
 4: EX-10       Ex-10.4                                             HTML     47K 
 5: EX-31       Ex-31.1                                             HTML     27K 
 6: EX-31       Ex-31.2                                             HTML     28K 
 7: EX-32       Ex-32.1                                             HTML     21K 
 8: EX-32       Ex-32.2                                             HTML     22K 
64: R1          Document and Entity Information                     HTML     41K 
45: R2          Consolidated Balance Sheets                         HTML    136K 
42: R3          Consolidated Balance Sheets (Parenthetical)         HTML     48K 
17: R4          Consolidated Statements Of Operations And           HTML    105K 
                Comprehensive Loss                                               
44: R5          Consolidated Statements Of Cash Flows               HTML    144K 
31: R6          Basis of Presentation                               HTML     55K 
57: R7          Recent Accounting Pronouncements                    HTML     30K 
32: R8          Stock-Based Awards and Per Share Information        HTML    222K 
34: R9          Inventory                                           HTML     37K 
18: R10         Property, Plant, and Equipment                      HTML     53K 
33: R11         Intangible Assets and Goodwill                      HTML    101K 
56: R12         Accrued Liabilities and Deferred Revenue            HTML    110K 
52: R13         Lines Of Credit and Other Borrowings                HTML     55K 
43: R14         Commitments and Contingencies                       HTML     42K 
61: R15         Segment Information                                 HTML     56K 
55: R16         Concentrations                                      HTML     28K 
15: R17         Income Taxes                                        HTML     41K 
20: R18         Subsequent Event                                    HTML     22K 
60: R19         Accounting Policies (Policies)                      HTML    114K 
63: R20         Stock-Based Awards and Per Share Information        HTML    192K 
                (Tables)                                                         
65: R21         Inventory (Tables)                                  HTML     34K 
62: R22         Property, Plant, and Equipment (Tables)             HTML     49K 
47: R23         Intangible Assets and Goodwill (Tables)             HTML     93K 
19: R24         Accrued Liabilities and Deferred Revenue (Tables)   HTML    116K 
30: R25         Segment Information (Tables)                        HTML     47K 
23: R26         Basis of Presentation - Additional Information      HTML     67K 
                (Detail)                                                         
22: R27         Classification of Compensation Expense Associated   HTML     29K 
                with Share-Based Payments (Detail)                               
36: R28         Assumptions Used in Estimating Fair Value of Stock  HTML     32K 
                Options Granted (Detail)                                         
46: R29         Summary of Option Activity (Detail)                 HTML     72K 
53: R30         Cash Proceeds Along with Fair Value Disclosures     HTML     39K 
                Related to grants Exercises and Vesting Options                  
                (Detail)                                                         
27: R31         Stock Based Awards and Per Share Information -      HTML    115K 
                Additional Information (Detail)                                  
37: R32         Components of Inventory (Detail)                    HTML     32K 
59: R33         Inventory - Additional Information (Detail)         HTML     25K 
25: R34         Summary of Property, Plant, and Equipment (Detail)  HTML     36K 
50: R35         Property, Plant, and Equipment - Additional         HTML     22K 
                Information (Detail)                                             
51: R36         Intangible Assets Related to Accumulated            HTML     52K 
                Amortization and Goodwill (Detail)                               
38: R37         Intangible Assets and Goodwill - Additional         HTML     24K 
                Information (Detail)                                             
21: R38         Components of Accrued Liabilities (Detail)          HTML     43K 
49: R39         Changes In Initial Product Warranty Accrual and     HTML     38K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
26: R40         Summary of Deferred Revenue (Detail)                HTML     37K 
35: R41         Lines of Credit and Other Borrowings - Additional   HTML    111K 
                Information (Detail)                                             
54: R42         Commitments and Contingencies - Additional          HTML     32K 
                Information (Detail)                                             
29: R43         Summary of Net Revenue by Geographic Location       HTML     24K 
                (Detail)                                                         
48: R44         Segment Information - Additional Information        HTML     30K 
                (Detail)                                                         
41: R45         Concentrations - Additional Information (Detail)    HTML     31K 
24: R46         Income Taxes - Additional Information (Detail)      HTML     57K 
58: R47         Subsequent Event - Additional Information (Detail)  HTML     21K 
40: XML         IDEA XML File -- Filing Summary                      XML     91K 
16: EXCEL       IDEA Workbook of Financial Reports                  XLSX    134K 
39: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.26M 
 9: EX-101.INS  XBRL Instance -- biol-20130930                       XML   1.59M 
11: EX-101.CAL  XBRL Calculations -- biol-20130930_cal               XML    132K 
12: EX-101.DEF  XBRL Definitions -- biol-20130930_def                XML    710K 
13: EX-101.LAB  XBRL Labels -- biol-20130930_lab                     XML    998K 
14: EX-101.PRE  XBRL Presentations -- biol-20130930_pre              XML    800K 
10: EX-101.SCH  XBRL Schema -- biol-20130930                         XSD    161K 
28: ZIP         XBRL Zipped Folder -- 0001564590-13-001200-xbrl      Zip    135K 


‘R41’   —   Lines of Credit and Other Borrowings – Additional Information (Detail)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.8
Lines of Credit and Other Borrowings - Additional Information (Detail) (USD $)
3 Months Ended 9 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Subsequent Event
Line of Credit
Line of Credit
Line of Credit
Line of Credit
Comerica Bank
Comerica Bank
September 2013 Comerica Warrant
September 2013 Comerica Warrant
2012 Comerica Warrant
2012 Comerica Warrant
November 2013 Comerica Warrant
Subsequent Event Warrant
Domestic Revolver Credit Facility
Domestic Revolver Credit Facility
Domestic Revolver Credit Facility
Domestic Revolver Credit Facility
Domestic Revolver Credit Facility
Prime rate
Ex-Im Revolver
Ex-Im Revolver
Ex-Im Revolver
Prime rate
Line Of Credit Facility [Line Items]                                                    
Lines of credit maximum borrowing capacity         $ 10,000,000 $ 8,000,000             $ 8,000,000             $ 4,000,000 $ 6,000,000 $ 4,000,000     $ 4,000,000  
Outstanding borrowings under lines of credit 5,500,000   5,500,000     1,600,000                         3,500,000         2,000,000    
Line of credit facility, expiration date     May 01, 2014                                              
Interest on principal balance rate plus                                             2.00%     1.50%
Prime floor rate based on undeterminable LIBOR rate         2.50%                                          
Unused capacity commitment fee percentage               0.25% 0.25% 0.25% 0.25%                              
Interest expense incurred for lines of credit               181,000 98,000 381,000 133,000                              
Accrued Interest Payable 9,000   9,000     19,000                                        
Amortization of deferred debt issuance costs 71,000 38,000 152,000 53,000                                            
Amortization of discount on lines of credit 43,000 18,000 79,000 25,000                                            
Minimum equity raise requirement by March 1, 2014 covenant             3,000,000                                      
Warrants issued to purchase common stock                             100,000   80,000 100,000                
Warrants price of warrants                             2.00   2.00 2.00                
Number of Comerica Bank warrants exercised                               80,000                    
Net issuance of common stock due to exercise of warrants                               40,465                    
Expiration date of warrant shares if unexercised                           Sep. 06, 2018       Nov. 08, 2018                
Fair value warrants expected term                           5 years                        
Fair value warrants volatility rate                           105.32%                        
Fair value warrants dividend per share                           $ 0.00                        
Fair value warrants risk free interest rate                           1.77%                        
Fair value of warrants                           143,000                        
Credit Agreements amendment fee             10,000         10,000                            
Financed insurance premium 0   0     379,000                                        
Number of monthly insurance premium installments payable in 2013     Nine                                              
Financial insurance premiums interest rate 3.00%   3.00%     3.00%                                        
Interest expense incurred for financed insurance premiums $ 1,000 $ 0 $ 5,000 $ 4,000                                            

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
11/8/18
9/6/18
5/1/14
Filed on:11/12/138-K
11/8/13
For Period end:9/30/13
9/6/138-K,  8-K/A
5/7/138-K
3/31/1310-Q
12/31/1210-K
9/30/1210-Q
9/15/09
 List all Filings 
Top
Filing Submission 0001564590-13-001200   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 4:41:47.0am ET